X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.juvisepharmaceuticals.com/wp-content/uploads/2020/04/Press-Release-Dartmouth-20122019-Eng-Juvis%C3%A9-Final.pdf
http://www.pharmafile.com/news/536087/astrazeneca-sells-amrimidx-and-casodex-european-rights-juvis-pharmaceuticals
https://www.fiercepharma.com/pharma/asco-pfizer-astellas-xtandi-racks-up-more-data-for-new-prostate-cancer-use
https://www.pharmacompass.com/pdf/news/anvisa-suspends-batch-of-casodex-bicalutamide-50mg-1519448434.pdf
https://www.prnewswire.com/news-releases/ani-pharmaceuticals-acquires-four-ndas-from-astrazeneca-for-465-million-300576084.html
http://www.pharmatimes.com/news/az_books_3_percent_sales_drop_for_q3_1210956
http://www.prnewswire.com/news-releases/fda-approves-supplemental-new-drug-application-for-xtandi-enzalutamide-capsules-in-advanced-prostate-cancer-300349215.html
https://www.pharmacompass.com/pdf/news/zhejiang-hisun-pharmaceutical-co-ltd-yantou-campus-fails-edqm-inspection-1483966941.pdf
http://www.prnewswire.com/news-releases/journal-of-clinical-oncology-publishes-results-from-the-strive-trial-of-enzalutamide-compared-to-bicalutamide-in-castration-resistant-prostate-cancer-300210093.html
http://www.prnewswire.com/news-releases/lancet-oncology-publishes-results-from-the-phase-2-terrain-trial-of-enzalutamide-compared-to-bicalutamide-in-metastatic-castration-resistant-prostate-cancer-300203638.html
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/091011Orig1s000ltr.pdf
http://newsinfo.inquirer.net/680618/fda-warns-vs-20-unregistered-drugs
Market Place
Share 
